X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (618) 618
humans (475) 475
pharmacology & pharmacy (351) 351
male (244) 244
extended-release (234) 234
double-blind (201) 201
female (199) 199
animals (160) 160
extended-release naltrexone (152) 152
adult (150) 150
psychiatry (150) 150
delayed-action preparations (144) 144
opioids (124) 124
efficacy (119) 119
substance abuse (118) 118
analysis (117) 117
care and treatment (115) 115
middle aged (110) 110
naltrexone (101) 101
drug therapy (93) 93
pharmacokinetics (92) 92
treatment outcome (89) 89
clinical neurology (87) 87
drugs (86) 86
narcotics (81) 81
medicine & public health (78) 78
article (77) 77
pain (76) 76
buprenorphine (75) 75
placebo-controlled trial (74) 74
schizophrenia (74) 74
extended release (73) 73
safety (73) 73
analgesics, opioid - administration & dosage (71) 71
neurosciences (71) 71
pharmacotherapy (70) 70
aged (66) 66
drug abuse (63) 63
drug delivery systems (62) 62
internal medicine (60) 60
research (60) 60
united-states (60) 60
double-blind method (58) 58
medicine, general & internal (57) 57
quality-of-life (57) 57
dosage and administration (55) 55
opioid-related disorders - drug therapy (55) 55
naltrexone - administration & dosage (54) 54
pharmacology/toxicology (54) 54
randomized controlled-trial (54) 54
clinical trials (53) 53
young adult (52) 52
dependence (51) 51
extended-release niacin (51) 51
naltrexone - therapeutic use (51) 51
narcotic antagonists - administration & dosage (51) 51
pharmacology (48) 48
administration, oral (47) 47
medicine, research & experimental (46) 46
methadone (46) 46
narcotic antagonists - therapeutic use (46) 46
analgesics (45) 45
analgesics, opioid - adverse effects (45) 45
heroin (44) 44
open-label (44) 44
usage (44) 44
analgesics, opioid - therapeutic use (43) 43
rats (43) 43
review (43) 43
extended-release tablets (42) 42
health aspects (42) 42
substance abuse treatment (42) 42
therapy (42) 42
prevention (41) 41
chemistry, pharmaceutical (40) 40
morphine (40) 40
overactive bladder (40) 40
patients (40) 40
chronic pain (39) 39
management (39) 39
studies (39) 39
time factors (39) 39
dose-response relationship, drug (38) 38
quality of life (38) 38
tablets (38) 38
adolescent (37) 37
extended-release oxycodone (37) 37
opioid dependence (37) 37
pain - drug therapy (37) 37
addiction (36) 36
drug dosages (36) 36
injections (35) 35
overdose (35) 35
psychology, clinical (35) 35
risk factors (35) 35
formulations (34) 34
medical research (34) 34
risperidone (34) 34
toxicology (34) 34
antipsychotic agents - therapeutic use (33) 33
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (879) 879
German (3) 3
Japanese (3) 3
Russian (2) 2
Chinese (1) 1
French (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
PARASITES & VECTORS, ISSN 1756-3305, 05/2019, Volume 12, Issue 1, pp. 231 - 6
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 10/2019, Volume 569, p. 118611
The new frontier of medicine is the personalization of treatment to match a patient’s individual needs. Fused-filament fabrication (FFF) offers a platform for... 
Hot-melt extrusion | Mass-customization | Bilayer tablets | Injection molding | Oral tablets | Lovastatin | Hydrochlorothiazide | Personalized medicine | 3D printing | DELIVERY-SYSTEMS | DOSAGE FORMS | AMORPHOUS SOLID DISPERSIONS | DRUG-RELEASE | IMMEDIATE | BIOAVAILABILITY | PHARMACOLOGY & PHARMACY | EXTENDED-RELEASE
Journal Article
Journal of Substance Abuse Treatment, ISSN 0740-5472, 09/2019, Volume 104, pp. 64 - 71
Journal Article
Current Medical Research and Opinion, ISSN 0300-7995, 05/2018, Volume 34, Issue 5, pp. 893 - 901
Background: The development and use of abuse-deterrent (AD) opioids is part of a multifaceted strategy to reduce misuse, abuse, and diversion, while... 
Abuse-deterrent | human abuse potential | extended-release | opioid | morphine | ARYMO ER | UNITED-STATES | OXYCODONE | MEDICINE, RESEARCH & EXPERIMENTAL | IMMEDIATE-RELEASE | CHRONIC PAIN | SAFETY | SEQUESTERED NALTREXONE | MEDICINE, GENERAL & INTERNAL | PHARMACOKINETICS | FORMULATIONS | DOUBLE-BLIND | USERS
Journal Article
British Journal of Anaesthesia, ISSN 0007-0912, 03/2019, Volume 122, Issue 3, pp. 379 - 387
An injectable liposomal bupivacaine suspension (EXPAREL™) is approved by the US Food and Drug Administration for analgesia by tissue infiltration and... 
local anaesthetics | spinal anaesthesia | bupivacaine | liposomes | extended-release preparations | DEPOFOAM(TM) | MANAGEMENT | DRUG-DELIVERY SYSTEM | BLOCK | TRIAL | HCL | PAIN | POSTSURGICAL ANALGESIA | ANESTHESIOLOGY | RELEASE EPIDURAL MORPHINE | DEPODUR(TM) | Index Medicus
Journal Article
Journal Article
Journal Article